Professor, Medicine, UCSD School of Medicine
Rheumatology
Dr. Kenneth C. Kalunian, MD
|
|
Give Review
Kenneth Kalunian works in the field of Rheumatology. He graduated from Saint Louis University School of Medicine. Saint Louis University School of Medicine is ranked 67 in research and 57 in primary care medicine He over the years received 3 awards: "CMS Meaningful Use Stage 1 Certification", "Fellow (FACR)" and "Fellow". Kenneth Kalunian is a published physician as well. He has 21 publications published. The latest was: Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, ... He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Efficacy and safety of subcutaneous tabalumab in patients with systemic Lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, ...
- Anti-C1q antibodies in systemic Lupus erythematosus.
- Factors associated with damage accrual in patients with systemic Lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Incep...
- Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE tri...
- Utility of the ultrasound examination of the hand and wrist joints in the management of established rheumatoid Arthritis.
- Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic Lupus erythematosus: results from two randomized, double-blind, placebo-controlled...
- Sifalimumab, a human anti-interferon-a monoclonal antibody, in systemic Lupus erythematosus: A phase 1 randomized controlled, dose-escalation study.
- Efficacy and safety of epratuzumab in patients with moderate/severe active systemic Lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, pl...
- Measurement of Cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus.
- CXCL13 as a marker for outcome of rheumatoid Arthritis: Comment on the article by Meeuwisse et al.
- New developments in osteoArthritis.
- Validation of American College of Rheumatology classification criteria for knee osteoArthritis using arthroscopically defined cartilage damage scores.
- The effect of combined estrogen and progesterone hormone replacement therapy on Disease activity in systemic lupus erythematosus: a randomized trial.
- Calcium-containing crystals and osteoArthritis: implications for the clinician.
- Effects of prasterone on Disease activity and symptoms in women with active systemic lupus erythematosus.
- Linkage and interaction of loci on 1q23 and 16q12 may contribute to susceptibility to systemic Lupus erythematosus.
- Familiality and co-occurrence of clinical features of systemic lupus erythematosus.
- Can Women with Systemic Lupus Erythematosus Safely Use Exogenous Estrogens?
- Cell-bound complement activation products in systemic lupus erythematosus: comparison with anti-double-stranded DNA and standard complement measurements.
- Work disability, lost productivity and associated risk factors in patients diagnosed with systemic Lupus erythematosus.
Schools
Saint Louis University School Of Medicine
Vet Affairs Med Center
Vet Affairs Med Center W La
Procedures Preformed
- Joint Drainage
Conditions Treated
- Adhesive Capsulitis
- Amyloidosis
- Ankylosing Spondylitis
- Antiphospholipid Syndrome (APS)
- View All
Doctors Specialties
- Rheumatology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACR)
- Fellow
Education
-
UCLA Medical Center -
UCLA - San Fernando Valley Program -
Saint Louis University School of Medicine
Hospital
-
UC San Diego Health
Drug Facts
| NPI NUMBER | 1346269990 | |
| NPPES Provider LastName | KALUNIAN | |
| NPPES Provider FirstName | KENNETH | |
| NPPES Provider ZIPCode | 920935004 | |
| NPPES Provider State | CA | |
| Specialty Description | Rheumatology | |
| Total Claim Count | 401.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 25.0 | |
| Percent Opioid Claims | 6.23 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1346269990 |
| Last Name Of The Provider | KALUNIAN |
| First Name Of The Provider | KENNETH |
| View All |
Similar Doctors
|
|
Dr. Raymond I. Press, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zdenka Fronek, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeannie H. Chao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Natasha S. Conley, DO |
|
|
Dr. Katherine H. Nguyen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Akther J. Kotha, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul Y. Liu, MD |
|
|
Dr. Harry E. Gruber, MD |
|
|
Dr. Louise H. Keogh, MD |
|
|
Dr. Alan M. Solinger, MD |
|
|
Dr. Monica C. Sandu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Quinn E. Whiting-Okeefe, MD |
|
Dr. Nunzio Bottini, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan E. Sweeney, MD |
|
|
Dr. Rachel P. Kim, MD |
|
|
Dr. Chris M. Storgard, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ying Wu, MD |